Literature DB >> 16499503

What drug policies cost: estimating government drug policy expenditures.

Peter Reuter1.   

Abstract

AIMS: Many nations now spend large sums of government money to reduce drug problems. The size and composition of public expenditures aimed at reducing drug use and related problems (a drug budget) is a useful partial description of a nation's drug policy. This paper examines whether it is possible to estimate these sums in a consistent manner across nations.
METHODS: Past drug budget efforts in the United Kingdom and United States were reviewed. A new methodology was offered for estimation and used for estimates of expenditures in the Netherlands and Sweden. Using this methodology, expenditures were compared.
FINDINGS: In both the Netherlands and Sweden, with very different official drug policy rhetoric, enforcement expenditures dominate the total; prevention expenditures are a tiny share. The baseline estimates indicate that the Netherlands, by a variety of metrics (e.g. Euros per capita, Euros per problematic user), spends more on drug control, even enforcement, than Sweden but the range of estimates is such that this cannot be inferred with confidence.
CONCLUSION: Estimating total government expenditures on reducing drug use and related problems is feasible and can yield useful policy insights.

Entities:  

Mesh:

Year:  2006        PMID: 16499503     DOI: 10.1111/j.1360-0443.2005.01336.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  7 in total

1.  Labelled drug-related public expenditure in relation to gross domestic product (GDP) in Europe: a luxury good?

Authors:  Luis Prieto
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-05-17

2.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

3.  Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach.

Authors:  Björn Stollenwerk; Thomas Welchowski; Matthias Vogl; Stephanie Stock
Journal:  Eur J Health Econ       Date:  2015-02-04

4.  Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison.

Authors:  Andrew J Sutton; W John Edmunds; O Noel Gill
Journal:  BMC Public Health       Date:  2006-06-27       Impact factor: 3.295

5.  Methamphetamine use and rates of incarceration among street-involved youth in a Canadian setting: a cross-sectional analysis.

Authors:  M-J Milloy; Thomas Kerr; Jane Buxton; Julio Montaner; Evan Wood
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-08-12

Review 6.  Comparing alcohol policies between countries: science or silliness?

Authors:  Alison Ritter
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

7.  Five-Factor Model personality profiles of drug users.

Authors:  Antonio Terracciano; Corinna E Löckenhoff; Rosa M Crum; O Joseph Bienvenu; Paul T Costa
Journal:  BMC Psychiatry       Date:  2008-04-11       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.